Interim Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
PATIENT REVENUES, net	$ 97,945	$ 95,225
EXPENSES:
Operating	78,618	77,145
Lease and rent expense	7,252	7,145
Professional liability	2,066	2,155
General and administrative	6,734	6,051
Depreciation and amortization	2,003	1,879
Total expenses	96,673	94,375
OPERATING INCOME	1,272	850
OTHER EXPENSE:
Equity in net income of unconsolidated affiliate	33	108
Interest expense, net	(1,070)	(950)
Debt retirement costs	(351)	0
Total other expense	(1,388)	(842)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(116)	8
BENEFIT (PROVISION) FOR INCOME TAXES	42	(3)
Income (loss) from continuing operations	(74)	5
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit of $21 and $168, respectively	(37)	(263)
NET LOSS	$ (111)	$ (258)
Per common share – basic
Continuing operations (in dollars per share)	$ (0.01)	$ 0.00
Discontinued operations (in dollars per share)	(0.01)	(0.04)
Net loss per common share – basic	(0.02)	(0.04)
Per common share – diluted
Continuing operations (in dollars per share)	(0.01)	0.00
Discontinued operations (in dollars per share)	(0.01)	(0.04)
Net loss per common share – diluted	(0.02)	(0.04)
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK	$ 0.055	$ 0.055
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	6,160	6,045
Diluted (shares)	6,160	6,045